Dobris

Czechia

5 total trials

Filter these 5 trials by phase, condition, sponsor and more.

Open in Search →

A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain Ended recruitment

2023-506127-29-00 4 2024-03-05 Diabetic Peripheral Neuropathy
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended recruitment

2022-501608-85-00 5 2023-05-09 Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2) Ended

2022-502837-24-00 5 2023-09-25 Overweight
A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hype … Ended

2022-503022-13-00 5 2023-06-08 Hypertriglyceridemia, Cardiovascular Diseases, Atherosclerosis
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia Ended

2022-501420-20-00 5 2023-05-17 Severe hypertryglyceridemia

Showing 1–5 of 5 trials